Akero Therapeutics’ Product Efruxifermin Demonstrates Strong Positive Results in NASH Patients
July 1, 2020
0
Akero Therapeutics Efruxifermin Positive Results in NASH Akero Therapeutics (AKRO) results of a 16-week analysis of secondary …